Dec 10 (Reuters) - A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid ...

Pomalyst (pomalidomide) is a brand-name oral capsule prescribed with dexamethasone to treat multiple myeloma in adults who have already tried at least two other treatments and whose cancer has ...

Darzalex (daratumumab) is a biologic medication used to treat a type of blood cancer called multiple myeloma in adults. Doctors use it for people who have just been diagnosed, as well as for patients ...

The FDA has issued a draft guidance for industry on use of minimal residual disease (MRD) and complete response rates as primary trial endpoints for accelerated approval of multiple myeloma drugs. In ...

“Many patients with multiple myeloma require cardiovascular medications. Our results support the idea that several common drug classes can often be continued without clear evidence of harming survival ...

Multiple myeloma is already served by therapies called T cell engagers, but toxicity remains a problem. GSK sees a way to overcome that limitation with a Chimagen Biosciences drug candidate it ...

Dec 10 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...